CRBP
CRBP Weekly AnalysisHello Traders!
The probability of what I analyzing, is to be true unless the opposite is proven
According to my analysis, this is my opinion about weekly chart for CORBUS PHARMACEUTICALS HOLDINGS (CRBP)
Feel free dear trader to share with me your opinion, and also your analysis & Keep Watching
CRBP double or triple jump very very soon! Been watching this stock for a bit. It finally is about to cross 200MA a strong indicator that it will pop soon and it's jumping (crossed above $2.5 about two days ago and touching $2 now. Put your bets in....timing is everything and it's starting to get hot!
Chaos Theory and Fractals: A forgotten name in HealthcareAbout the Tickers: Corbus Pharmaceuticals Holdings, Inc. NASDAQ:CRBP is a clinical-stage company focused on the development and commercialization of novel medicines designed to target the endocannabinoid system. The Company’s lead product candidate, lenabasum, is a novel, oral, selective cannabinoid receptor type 2 (CB2) agonist designed to provide an alternative to immunosuppressive medications in the treatment of chronic inflammatory and fibrotic diseases. Lenabasum is currently being evaluated in dermatomyositis and systemic lupus erythematosus. Corbus is also developing a pipeline of other preclinical drug candidates from its endocannabinoid system platform. Phase 3 trial of Lenabasum in Systemic Sclerosis was unsuccessful last year. Currently, a phase 3 trial in Dermatomyositis is scheduled to read out top line results by Q2 2021.
The Chart: Appears similar to Cassava NASDAQ:SAVA which also saw setbacks and plunged to about $1 a share. Can we use fractals and chaos theory to predict the price of $CRBP stock in the near term? Possibly.
Corbus Pharmaceuticals ($CRBP) is currently trading at about $2 a share. Cassava Sciences ($SAVA) is trading at about $54 a share.
CRBP return to pre-covid?The stock has been above $5 most of the time.
It is only that Lenbasaum, their leading drug, has failed in one of the clinical studies, that is why the stock plummeted in Sep 2020.
Nonetheless, they have couple others ongoing studies and they may have a chance to recover to pre-covid levels.
Before the September news their ratings were Buy and Outperform at $12, $22 and even $40 levels.
Mind the fundamentals and news.
Am I overly Ambitious for a 7 to 1 ratio play on the $CRBP 4h?As volume increases and price action shows an agreement that's in sync with the micro bullish channel that started back in January, the chances of breaking R1 and R2 seem more prevalent. My focus would be the price range in between the previous gap-down. I may trade into crbp pre market Wednesday to initiate an intraweek- intra quarter swing trade.
$CRBP Major GapBeen adding on dips since Monday playing it as sympathy play of other cannabis stocks that are ripping, plus there's a huge gap to be filled if we can get a bullish candle over $3 that's when the scanners come in.
The volume has been increasing and creating higher lows on the hourly chart it tapped 3.04 today but got rejected quick once we get a nice pop this might run and fill the gap, again this are only my ideas trade them accordingly and good luck!
CRBP Daily - GAP POSSIBLE I am in this just because of the gigantic gap. Target is $4, with a chance (if it gets volume) to run up close to $6 which is where the last offering was.
No reason to do a bunch of DD or anything on this -I am simply playing the chart. Its going to run or its not....Stop loss during market hours, keep alerts on it during after hours.
TRADE YOUR PLAN.
$CRBP
$CRBP bull traction.CRBP looks like it's gaining a lot of positive attraction breaking previous sideways support and resistance.
Needs to break resistance @$2.55 and create a support to gain confidence for the bulls to drive up to pre-covid.
Do your own research as always but I'll be putting an order in @2.55 with a stop loss of 10% of that.
Open to thoughts and opinions on this company and it's future predictions.